if it does it will be the first time i have seen a biotech make it through the trial phase so hassle free...
normally always a couple of major hiccups along the way, thus far its been a dream run but can it continue?
the remarkable thing i always remember about biotechs was pxs completing its phase 3 trials and announcing that sales were due to commence. initially there was very little excitement from the market and the shares remained around 80cps for a few days. vcr is another, now closer than ever to making $$$ out of their heart pumps and yet it is miles off the highs it reached during its phase 2 trials.
i would be suprised if sla makes it through unscathed but could well be proven incorrect.
SLA Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
